BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806X902. A total of 4 filers reported holding BRIDGEBIO PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,871,774 | +31.5% | 450,200 | -14.2% | 0.00% | +33.3% |
| Q2 2023 | $9,026,560 | +72.7% | 524,800 | +66.5% | 0.00% | +50.0% |
| Q1 2023 | $5,226,016 | +3819.0% | 315,200 | +1701.1% | 0.00% | – |
| Q4 2022 | $133,350 | -85.0% | 17,500 | -80.4% | 0.00% | – |
| Q3 2022 | $887,000 | -40.3% | 89,200 | -45.5% | 0.00% | -100.0% |
| Q2 2022 | $1,487,000 | – | 163,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 160,200 | $1,626,000 | 0.00% |
| SIMPLEX TRADING, LLC | 125,200 | $1,270,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |